Analysis establishes PTH reference intervals in adults using KNHANES 2024 data, suggesting implications for bone health.
Parathyroid hormone (PTH) plays a pivotal role in calcium–phosphate metabolism and bone health; however, interpretation of PTH concentrations remains challenging because of biological variability and substantial analytical heterogeneity among assays. In Korea, population-based data on PTH reference intervals are limited, and assay-specific reference intervals have not been well established. We evaluated the reference interval of serum PTH using data from the Korea National Health and Nutrition Examination Survey (KNHANES) 2024. A stepwise, biologically informed selection process was applied to define reference populations by progressively excluding participants with conditions known to influence PTH metabolism, including impaired renal function, vitamin D insufficiency, and abnormalities in mineral-related biochemical parameters (calcium, magnesium, phosphate, and alkaline phosphatase). Among the 6,997 participants in the KNHANES 2024 dataset, serum PTH measurements were available for 4,502 adults aged ≥ 40 years. The high prevalence of supplement use and age-restricted sampling limited the size of suitable reference populations. The number of survey-design–valid participants frequently fell below the recommended threshold for reference interval estimation (< 120) after applying criteria for vitamin D sufficiency, mineral homeostasis, and age- and sex-specific alkaline phosphatase. Among 155 participants without a history of disease, not using dietary supplements, not pregnant, and with an estimated glomerular filtration rate ≥ 60 mL/min/1.73 m², the unweighted and survey-weighted 2.5th–97.5th reference intervals of PTH were 21.8–65.0 pg/mL and 20.5–67.7 pg/mL, respectively, when vitamin D status and serum calcium, magnesium, and phosphate levels were not considered. Future population-based studies incorporating broader age ranges and comprehensive biochemical profiling are needed to refine population- and assay-specific PTH reference intervals and to clarify their implications for bone health. Not applicable.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: